Free Trial

Compass Therapeutics (CMPX) Earnings Date, Estimates & Call Transcripts

$1.47
-0.03 (-2.00%)
(As of 05/24/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(Mar. 21)
-$0.11 Missed By -$0.02
Consensus EPS
(Mar. 21)
-$0.09
Skip Charts & View Estimated and Actual Earnings Data

CMPX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CMPX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Compass Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.14)($0.11)($0.13)
Q2 20243($0.11)($0.09)($0.10)
Q3 20243($0.13)($0.10)($0.11)
Q4 20243($0.13)($0.10)($0.12)
FY 202411($0.51)($0.40)($0.46)

CMPX Earnings Date and Information

Compass Therapeutics last issued its quarterly earnings data on March 21st, 2024. The reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.02. Compass Therapeutics has generated ($0.36) earnings per share over the last year (($0.36) diluted earnings per share). Earnings for Compass Therapeutics are expected to decrease in the coming year, from ($0.41) to ($0.45) per share. Compass Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Compass Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
3/21/2024Q4 2023($0.09)($0.11)($0.02)($0.11)--
11/9/2023Q3 2023($0.11)($0.08)+$0.03($0.08)--
8/3/2023Q2 2023($0.08)($0.09)($0.01)($0.09)--
5/4/2023Q1 2023($0.11)($0.06)+$0.05($0.06)--
3/15/2023Q4 2022($0.11)($0.10)+$0.01($0.10)--
11/9/2022Q3 2022($0.11)($0.12)($0.01)($0.12)--
8/1/2022Q2 2022($0.09)($0.08)+$0.01($0.08)--
5/9/2022Q1 2022($0.14)($0.07)+$0.07($0.07)--
3/21/2022Q4 2021($0.07)($0.15)($0.08)($0.15)--
11/11/2021Q3 2021($0.12)($0.10)+$0.02($0.10)--
8/16/2021Q2 2021-($1.07)($1.07)($1.07)--
4/30/2021Q1 2021-($0.14)($0.14)($0.14)--
3/5/2021Q4 2020-($0.08)($0.08)($0.08)--
11/9/2020Q3 2020-($0.18)($0.18)($0.18)--
8/13/2020Q2 2020-($0.41)($0.41)($0.41)--

Compass Therapeutics Earnings - Frequently Asked Questions

When is Compass Therapeutics's earnings date?

Compass Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on CMPX's earnings history.

Did Compass Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Compass Therapeutics (NASDAQ:CMPX) missed the analysts' consensus estimate of ($0.09) by $0.02 with a reported earnings per share (EPS) of ($0.11). Learn more on analysts' earnings estimate vs. CMPX's actual earnings.

How much profit does Compass Therapeutics generate each year?

Compass Therapeutics (NASDAQ:CMPX) has a recorded net income of -$42.49 million. CMPX has generated -$0.36 earnings per share over the last four quarters.

What is Compass Therapeutics's EPS forecast for next year?

Compass Therapeutics's earnings are expected to decrease from ($0.41) per share to ($0.45) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CMPX) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners